2.99
Alzamend Neuro Inc Aktie (ALZN) Neueste Nachrichten
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs - The Manila Times
What drives Alzamend Neuro Inc. stock priceTriple-digit profit margins - jammulinksnews.com
Is Alzamend Neuro Inc. a good long term investmentSuperior profit margins - jammulinksnews.com
What analysts say about Alzamend Neuro Inc. stockHigh-yield market plays - Autocar Professional
Alzamend Neuro Inc. Stock Analysis and ForecastFree Trend-Following Techniques - jammulinksnews.com
What drives NextNav Inc. Equity Warrant stock priceAccelerated earnings growth - Autocar Professional
Is NVIDIA Corporation a good long term investmentFree Risk Assessment Services - jammulinksnews.com
LMND.WS Stock Analysis and ForecastMarket-crushing profits - jammulinksnews.com
What drives SIFCO Industries Inc. stock priceFree Stock Market Trend Analysis - jammulinksnews.com
What analysts say about DLR.PRK stockHigh-velocity gains - jammulinksnews.com
What drives BETRW stock priceConsistently high yield - jammulinksnews.com
Is Gildan Activewear Inc. a good long term investmentTremendous gains - jammulinksnews.com
What institutions are buying Alzamend Neuro Inc. stock nowPortfolio Boosting Stock Alerts - Newser
How Alzamend Neuro Inc. stock performs during market volatilityFree Stock Market Insider Analysis - Newser
Why Alzamend Neuro Inc. stock attracts strong analyst attentionMassive Upside Selection - Newser
What makes Alzamend Neuro Inc. stock price move sharplyReliable Low Risk Signals - Newser
Alzamend Neuro (NASDAQ:ALZN) Trading Down 2% – Should You Sell? - Defense World
Alzamend Neuro Stock: A Green Day Hiding Red Flags for Traders - thekhabrilal
Alzamend Neuro (ALZN) Secures $5 Million in Private Placement | - GuruFocus
Fast-Tracked: $5M Investment Accelerates 5 Phase II Trials for Alzheimer's and Mental Health Breakthroughs - Stock Titan
Alzamend Neuro (NASDAQ:ALZN) Stock Rating Upgraded by Wall Street Zen - Defense World
Alzamend Neuro Soars 11.29% Post Reverse Split - AInvest
Citadel Advisors LLC Makes New Investment in Alzamend Neuro, Inc. (NASDAQ:ALZN) - Defense World
Alzamend Neuro, Inc. (NASDAQ:ALZN) Sees Significant Growth in Short Interest - Defense World
Alzamend Neuro, Inc. (NASDAQ:ALZN) Short Interest Down 18.6% in May - Defense World
Why Alzamend Neuro (ALZN.O) Plunged 30% – A Liquidity Crisis or Hidden Catalyst? - AInvest
Promising Pharmaceutical Stocks To Follow Today – May 29th - Defense World
Unraveling Alzamend Neuro's 30% Plunge: A Liquidity Crisis or Sector Sell-Off? - AInvest
Lithium Stocks To Consider – May 29th - Defense World
Alzamend Neuro begins phase II trial for novel lithium delivery system By Investing.com - Investing.com South Africa
Alzamend Neuro doses first patient in Phase II study of AL001 - TipRanks
Alzamend Neuro (ALZN) Begins Phase II Clinical Study of AL001 | - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):